No Data
No Data
Optime Care Expands Partnership With Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE
Express News | Optime Care Expands Partnership With Rigel Pharmaceuticals to Include Commercial Distribution for Tavalisse®
Express News | Rigel Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Rigel Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Rigel (RIGL) Surges 19.7%: Is This an Indication of Further Gains?
Rigel Pharmaceuticals Price Target Maintained With a $15.00/Share by Cantor Fitzgerald
No Data
No Data